Next Article in Journal
The Autonomous House: A Bio-Hydrogen Based Energy Self-Sufficient Approach
Next Article in Special Issue
Estimated Time for Occurrence of Smoking-Related Consequences among Pregnant and Non-Pregnant Women
Previous Article in Journal
Preventing Smoking in Young People: A Systematic Review of the Impact of Access Interventions
Previous Article in Special Issue
Smoking and the Risk of Upper Aero Digestive Tract Cancers for Men and Women in the Asia-Pacific Region
Article Menu

Export Article

Open AccessArticle
Int. J. Environ. Res. Public Health 2009, 6(4), 1530-1538; doi:10.3390/ijerph6041530

Real World Study to Evaluate the Effectiveness of Varenicline and Cognitive-Behavioural Interventions for Smoking Cessation

1
Smoking Cessation Clinic. Hospital Universitario de Bellvitge. Feixa Llarga s/n 08907 Hospitalet. Barcelona, Spain
2
Smoking Cessation Clinic. Hospital Universitario de Vall d’Hebron. Passeig de la Vall d’Hebron 119-129. 08035 Barcelona, Spain
*
Author to whom correspondence should be addressed.
Received: 10 March 2009 / Accepted: 16 April 2009 / Published: 21 April 2009
(This article belongs to the Special Issue Tobacco Smoking and Public Health)
View Full-Text   |   Download PDF [131 KB, uploaded 19 June 2014]   |  

Abstract

A prospective pragmatic interventional study was conducted to evaluate the effectiveness of varenicline for smoking cessation among a cohort of motivated smokers attending two smoking cessation clinics. Smokers between 18 and 65 years who had smoked 10 or more cigarettes per day were included. All participants received cognitive-behavioural varenicline according to approved dose and prescriptions. Continuous abstinence, validated by exhaled CO levels, was assessed in each control. A total of 264 smokers – 155 males (58.7%) and 109 females (41.3%) – were included. Mean age was 43.7, amount smoked was 23 cigarettes per day and 61.4% had at least one prior attempt to quit. The continuous abstinence rate at end of treatment (12 wks) was 58.3%. Conclusions: varenicline and cognitive-behavioural intervention are effective for smoking cessation with high continuous abstinence rates when are used in a clinical setting. View Full-Text
Keywords: Smoking cessation; varenicline; cognitive-behavioural intervention; continuous abstinence Smoking cessation; varenicline; cognitive-behavioural intervention; continuous abstinence
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Ramon, J.M.; Bruguera, E. Real World Study to Evaluate the Effectiveness of Varenicline and Cognitive-Behavioural Interventions for Smoking Cessation. Int. J. Environ. Res. Public Health 2009, 6, 1530-1538.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top